PRE Stock Overview
A health sciences company, focuses on advancing consumer and clinical health. More details
| Snowflake Score | |
|---|---|
| Valuation | 1/6 |
| Future Growth | 2/6 |
| Past Performance | 0/6 |
| Financial Health | 4/6 |
| Dividends | 0/6 |
My Notes
Capture your thoughts, links and company narrative
Prenetics Global Limited Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | US$5.41 |
| 52 Week High | US$7.84 |
| 52 Week Low | US$2.85 |
| Beta | -0.31 |
| 1 Month Change | -6.72% |
| 3 Month Change | 17.10% |
| 1 Year Change | 6.29% |
| 3 Year Change | -95.33% |
| 5 Year Change | n/a |
| Change since IPO | -95.36% |
Recent News & Updates
Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 32% Share Price Bounce
Dec 16
Prenetics Global Limited's (NASDAQ:PRE) Earnings Haven't Escaped The Attention Of Investors
Oct 12Recent updates
Prenetics Global Limited's (NASDAQ:PRE) P/S Is Still On The Mark Following 32% Share Price Bounce
Dec 16Prenetics Global Limited's (NASDAQ:PRE) Earnings Haven't Escaped The Attention Of Investors
Oct 12Prenetics Global Limited (NASDAQ:PRE) Looks Just Right With A 29% Price Jump
May 29Prenetics Global Limited's (NASDAQ:PRE) 36% Cheaper Price Remains In Tune With Revenues
Apr 08Prenetics Global Limited (NASDAQ:PRE) Held Back By Insufficient Growth Even After Shares Climb 30%
Jan 07Prenetics Global GAAP EPS of -$2.91, revenue of $51.72M
Sep 09Shareholder Returns
| PRE | US Healthcare | US Market | |
|---|---|---|---|
| 7D | -5.3% | 2.2% | -0.5% |
| 1Y | 6.3% | 0.3% | 24.3% |
Return vs Industry: PRE exceeded the US Healthcare industry which returned -0.1% over the past year.
Return vs Market: PRE underperformed the US Market which returned 25.2% over the past year.
Price Volatility
| PRE volatility | |
|---|---|
| PRE Average Weekly Movement | 9.8% |
| Healthcare Industry Average Movement | 7.8% |
| Market Average Movement | 6.5% |
| 10% most volatile stocks in US Market | 18.8% |
| 10% least volatile stocks in US Market | 3.3% |
Stable Share Price: PRE has not had significant price volatility in the past 3 months compared to the US market.
Volatility Over Time: PRE's weekly volatility (10%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2014 | 322 | Danny Yeung | www.prenetics.com |
Prenetics Global Limited, a health sciences company, focuses on advancing consumer and clinical health. The company’s consumer initiatives is led by IM8, a new health and wellness brand. Its prevention arm, CircleDNA, uses next-generation sequencing (NGS) technology to offer comprehensive consumer DNA test.
Prenetics Global Limited Fundamentals Summary
| PRE fundamental statistics | |
|---|---|
| Market cap | US$67.19m |
| Earnings (TTM) | -US$45.79m |
| Revenue (TTM) | US$25.56m |
2.6x
P/S Ratio-1.4x
P/E RatioIs PRE overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| PRE income statement (TTM) | |
|---|---|
| Revenue | US$25.56m |
| Cost of Revenue | US$11.39m |
| Gross Profit | US$14.17m |
| Other Expenses | US$59.95m |
| Earnings | -US$45.79m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | -3.75 |
| Gross Margin | 55.43% |
| Net Profit Margin | -179.12% |
| Debt/Equity Ratio | 0% |
How did PRE perform over the long term?
See historical performance and comparisonCompany Analysis and Financial Data Status
| Data | Last Updated (UTC time) |
|---|---|
| Company Analysis | 2025/01/30 08:09 |
| End of Day Share Price | 2025/01/30 00:00 |
| Earnings | 2024/09/30 |
| Annual Earnings | 2023/12/31 |
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
| Package | Data | Timeframe | Example US Source * |
|---|---|---|---|
| Company Financials | 10 years |
| |
| Analyst Consensus Estimates | +3 years |
|
|
| Market Prices | 30 years |
| |
| Ownership | 10 years |
| |
| Management | 10 years |
| |
| Key Developments | 10 years |
|
* example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .
Analyst Sources
Prenetics Global Limited is covered by 1 analysts. 1 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.
| Analyst | Institution |
|---|---|
| Ross Osborn | Cantor Fitzgerald & Co. |